Literature DB >> 23996536

Overexpression of Rho-GDP-dissociation inhibitor-γ inhibits migration of neural stem cells.

Jiao Wang1, Xiao Li, Hua Cheng, Kai Wang, Wei Lu, Tieqiao Wen.   

Abstract

Neural stem cell (NSC) migration relies heavily on the regulation of actin and microtubule cytoskeletons by Rho GTPases, which are critical regulators of key steps during NSC migration. However, the migration mechanism remains unclear. Rho-GDP-dissociation inhibitor-γ (Rho-GDIγ) was identified as an important downregulator of the Rho family of GTPases, because of its ability to prevent nucleotide exchange and thus membrane association. This study investigates the role of Rho-GDIγ in neural stem cells migration. Our results indicate that the overexpression of Rho-GDIγ maintains NSCs in the stem cell state, meanwhile preventing NSC migration through inhibition of Rac1 expression, one of the Rho-family GTPases. This study provides the basis for further study of the molecular mechanism of NSC migration.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Rac1; Rho-GDIγ; migration; neural stem cell

Mesh:

Substances:

Year:  2013        PMID: 23996536     DOI: 10.1002/jnr.23261

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  4 in total

Review 1.  Role of Rho GTPases in stem cell regulation.

Authors:  Zheng Zhang; Ming Liu; Yi Zheng
Journal:  Biochem Soc Trans       Date:  2021-12-17       Impact factor: 5.407

2.  RhoGDIα suppresses self-renewal and tumorigenesis of glioma stem cells.

Authors:  Fan Wu; Peishan Hu; Dengke Li; Yan Hu; Yingjiao Qi; Bin Yin; Tao Jiang; Jiangang Yuan; Wei Han; Xiaozhong Peng
Journal:  Oncotarget       Date:  2016-09-20

3.  A biosystems approach to identify the molecular signaling mechanisms of TMEM30A during tumor migration.

Authors:  Jiao Wang; Qian Wang; Dongfang Lu; Fangfang Zhou; Dong Wang; Ruili Feng; Kai Wang; Robert Molday; Jiang Xie; Tieqiao Wen
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

4.  Verification of EZH2 as a druggable target in metastatic uveal melanoma.

Authors:  Bei Jin; Ping Zhang; Hailin Zou; Huijing Ye; Yun Wang; Jing Zhang; Huasheng Yang; Jingxuan Pan
Journal:  Mol Cancer       Date:  2020-03-04       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.